Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px
All >

News > Western Europe

Please find below news about Austria, Belgium, France, Germany, Liechtenstein, Luxembourg, Monaco, the Netherlands and Switzerland as well as about organisations from these countries.

Total search results: 11411 | Ordered by Date (descending)
1 2 3 ... 113 114 115  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Berlin Partner. (April 2019). "Special Feature: BIONNALE 2019 in Berlin – the Networking Event for the Life Sciences & Healthcare Industries in the German Capital Region". Berlin. 2019-04-21
[iito] Business Intelligence. (April 2019). "Special Feature: [iito] Relaunches Life-Sciences-UK.com & Life-Sciences-France.com". Bremen. 2019-04-20
HalioDx S.A.S.. (4/19/19). "Press Release: HalioDx Signs an Exclusive Agreement with Genecast to Make Immunoscore Available in China". Marseille. 2019-04-19
Arrakis Therapeutics, Inc.. (4/18/19). "Press Release: Arrakis Therapeutics Announces $75 Million Series B Financing To Advance a New Class of Small-Molecule Medicines Targeting RNA". Waltham, MA. 2019-04-18
PureTech Health plc. (4/17/19). "Press Release: PureTech Health Announces Collaboration with Boehringer Ingelheim to Advance Immuno-oncology Product Candidates Using Its Lymphatic Targeting Platform". Boston, MA. 2019-04-17
Kiadis Pharma N.V.. (4/17/19). "Press Release: Kiadis to Acquire CytoSen Therapeutics, Inc.". Amsterdam. 2019-04-17
Cerenis Therapeutics S.A.. (4/17/19). "Press Release: Cerenis Therapeutics Has Decided to Terminate the Proposed Merger with H4Orphan Pharma". Toulouse. 2019-04-17
Lipotype GmbH. (4/16/19). "Press Release: Worldwide First and Only Shotgun Lipidomics Service Provider with Official GMP Certificate". Dresden. 2019-04-16
Cevec Pharmaceuticals GmbH. (4/16/19). "Press Release: Cevec Closes Major Financing Round to Further Expand and Commercialize Its Viral Vector Manufacturing Platform". Cologne. 2019-04-16
MLM Medical Labs GmbH. (4/15/19). "Press Release: Innovative Medicines Initiative Launches Translational Safety Biomarker Pipeline Project to Enable Development and Implementation of Novel Safety Biomarkers". Mönchengladbach. 2019-04-15
Immunic, Inc.. (4/12/19). "Press Release: Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases". San Diego, CA & Martinsried. 2019-04-12
Curetis N.V.. (4/12/19). "Press Release: Curetis’ Subsidiary Ares Genetics Introduces NGS Services for Pharma and Public Health Sector at Upcoming ECCMID 2019". Vienna, Holzgerlingen & Amsterdam. 2019-04-12
Sophia Genetics S.A.. (4/11/19). "Press Release: Sophia Genetics Achieves CE-IVD Milestone for Its Solid Tumor Solution for Accurate Cancer Detection". Lausanne. 2019-04-11
Evotec SE. (4/11/19). "Press Release: Evotec and Indivumed Announce Strategic Drug Discovery Collaboration on Precision Medicine for Colorectal Cancer". Hamburg. 2019-04-11
Curetis N.V.. (4/11/19). "Press Release: Curetis Publishes Full-Year 2018 Financial Results and Updated Guidance for 2019". Amsterdam & Holzgerlingen. 2019-04-11
Centogene AG. (4/10/19). "Press Release: Centogene Launches CentoMetabolic Panel for Integrated Multiomic Testing for Metabolic Diseases". Rostock & Berlin. 2019-04-10
Synaffix B.V.. (4/10/19). "Press Release: Synaffix Announces $125m License Agreement with Shanghai Miracogen". Amsterdam. 2019-04-10
UCB S.A.. (4/9/19). "Press Release: FDA Approves Evenity (Romosozumab) for the Treatment Of Osteoporosis in Postmenopausal Women at High Risk for Fracture". Brussels. 2019-04-09
Theranexus S.A.. (4/9/19). "Press Release: Theranexus Announces Research Collaboration with IRISA Using Artificial Intelligence Technologies to Enhance Therapeutic Targeting of Neurological Interactions". Lyon. 2019-04-09
Bruker Corporation. (4/9/19). "Press Release: DKSH and Bruker AXS Strengthen Partnership in China". Shanghai. 2019-04-09
Probiodrug AG. (4/9/19). "Press Release: Probiodrug Raises EUR 8.2 Million from Investors in Successful Private Placement of New Shares [NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Halle (Saale). 2019-04-09
Uniqure N.V.. (4/8/19). "Press Release: Uniqure Receives FDA Fast Track Designation for AMT-130 Gene Therapy for the Treatment of Huntington’s Disease". Lexington, MA & Amsterdam. 2019-04-08
Kymab Ltd.. (4/8/19). "Press Release: Kymab Appoints Simon Sturge as Chief Executive Officer". Cambridge. 2019-04-08
Phenex Pharmaceuticals AG. (4/5/19). "Press Release: Phenex Collaborates with Mathias Heikenwälder’s Research Group from DKFZ (German Cancer Research Center)". Ludwigshafen. 2019-04-05
Eppendorf AG. (4/5/19). "Press Release: Eppendorf AG Increases Sales and Earnings in 2018 and Accelerates Organic Growth". Hamburg. 2019-04-05
Probiodrug AG. (4/4/19). "Press Release: Probiodrug AG has Mandated Oddo Seydler Bank AG as Designated Sponsor. The Shares Are Trading on XETRA, the Electronic Trading Platform of Deutsche Börse". Halle (Saale). 2019-04-04
Curetis N.V.. (4/4/19). "Press Release: Study Data Presented at ECCMID 2019 Confirm Clinical Benefits of Unyvero Platform". Amsterdam, San Diego, CA & Holzgerlingen. 2019-04-04
Novartis AG. (4/4/19). "Press Release: Novartis Updates on the Migraine Collaboration with Amgen". Basel. 2019-04-04
Medigene AG. (4/4/19). "Press Release: Roivant and Sinovant Launch Cytovant Sciences in Partnership with Medigene to Develop Cellular Therapies in Asia". Martinsried & Hong Kong. 2019-04-04
Nanobiotix S.A.. (4/4/19). "Press Release: Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval". Paris & Cambridge, MA. 2019-04-04
Qiagen N.V.. (4/3/19). "Press Release: Qiagen and LabCorp Launch Collaboration to Provide Day-One Access for Patients to Innovative Companion Diagnostics at the Time of Drug Approvals". Hilden & Germantown, MD. 2019-04-03
AgomAb Therapeutics N.V.. (4/3/19). "Press Release: AgomAb Therapeutics Completes Euros 21m Series A Financing". Ghent. 2019-04-03
ERS Genomics Ltd.. (4/3/19). "Press Release: European Patent Office Grants 3rd Charpentier/Doudna Patent Covering Uses of CRISPR/cas9 in Human and Animal Cells". Dublin. 2019-04-03
Novartis AG. (4/3/19). "Press Release: Sandoz Resubmits Biosimilar Pegfilgrastim Application to US FDA". Holzkirchen. 2019-04-03
Dyne Therapeutics. (4/3/19). "Press Release: Dyne Therapeutics Launches with $50 Million Series A to Develop Targeted Therapies for Muscle Diseases". Cambridge, MA. 2019-04-03
Roche. (4/3/19). "Press Release: Roche and Spark Therapeutics, Inc. Announce Withdrawal and Refiling of Premerger Notification and Report Form under the HSR Act and Extension of Tender Offer for Shares of Spark Therapeutics, Inc.". Basel. 2019-04-03
Curetis N.V.. (4/2/19). "Press Release: Curetis Introduces Unyvero AMR Atlas to Support Adoption of Rapid DNA Testing for Antibiotic Resistance". Amsterdam & Holzgerlingen. 2019-04-02
Immunic AG. (4/2/19). "Press Release: Immunic Therapeutics to Present at the Needham Healthcare Conference on April 10". Planegg-Martinsried. 2019-04-02
Centogene AG. (4/2/19). "Press Release: Centogene Announces the Appointment of Dr. Flemming Ornskov to the Supervisory Board as Non-Executive Chairman". Rostock & Berlin. 2019-04-02
Lonza Group AG. (4/2/19). "Press Release: Lonza and Chr. Hansen in Joint Venture to Accelerate Momentum in Microbiome". Copenhagen & Basel. 2019-04-02
Nanobiotix S.A.. (4/2/19). "Press Release: Combination of First-in-Class NBTXR3, Radiotherapy, and Anti-PD-1 Immunotherapy Demonstrate Efficacy in Treating Resistant Pre-clinical in Vivo Models of Lung Cancer". Paris & Cambridge, MA. 2019-04-02
Evotec SE. (4/1/19). "Press Release: Evotec AG Completes Conversion into Evotec SE". Hamburg. 2019-04-01
MorphoSys AG. (4/1/19). "Press Release: Dr. Sarah Fakih Joins MorphoSys as Head of Corporate Communications and Investor Relations". Planegg. 2019-04-01
Roche. (4/1/19). "Press Release: Roche’s Ipatasertib in Combination with Tecentriq and Chemotherapy Shows Promising Anti-tumour Activity in Triple-negative Breast Cancer in Early Phase Trial". Basel. 2019-04-01
Novartis AG. (4/1/19). "Press Release: Novartis Adds Clinical and Preclinical Anti-inflammatory Programs to Portfolio with Acquisition of IFM Tre". Basel. 2019-04-01
Polyneuron Pharmaceuticals AG. (3/28/19). "Press Release: Polyneuron Raises CHF22.5 Million in Series A to Advance Novel Therapies for Autoimmune Diseases". Basel. 2019-03-28
Evotec AG. (3/28/19). "Press Release: Evotec AG Fiscal Year 2018 Results – Accelerated Growth and Strong Long-term Outlook". Hamburg. 2019-03-28
Probiodrug AG. (3/28/19). "Press Release: Probiodrug Reports Full Year 2018 Financial Results". Halle (Saale). 2019-03-28
Qiagen N.V.. (3/28/19). "Press Release: Qiagen Launches Novel Liquid Biopsy Solutions and NGS Panels with Seamlessly Integrated Bioinformatics to Support Advances in Cancer Research". Germantown, MD & Hilden. 2019-03-28
ProteoNic Biotechnology B.V.. (3/28/19). "Press Release: ProteoNic Biotechnology Licenses Protein Production Technology to Bayer". Leiden. 2019-03-28
Indivumed GmbH. (3/28/19). "Press Release: Indivumed Partners with Flagship Biosciences to Provide Global Tissue-Based Diagnostics Services". Hamburg & Westminster, CO. 2019-03-28
Celyad S.A.. (3/28/19). "Press Release: Celyad Appoints Filippo Petti as Chief Executive Officer. Dr Christian Homsy Continues as Non-executive Director and Chair of the Strategy Committee of the Board of Directors". Mont-Saint-Guibert. 2019-03-28
Celyad S.A.. (3/28/19). "Press Release: Celyad Reports Business Update and Full Year 2018 Financial and Operating Results". Mont-Saint-Guibert. 2019-03-28
Cellnovo. (3/28/19). "Press Release: Cellnovo Stops Manufacturing and Commercial Operations. Administrators Appointed at UK Subsidiary Have Actioned a Restructuring Plan to Focus on Identifying Strategic Partners and Investors". Paris. 2019-03-28
Cerenis Therapeutics S.A.. (3/27/19). "Press Release: Cerenis Therapeutics and H4Orphan Pharma Enter into Exclusive Negotiations to Consider a Strategic Merger". Toulouse. 2019-03-27
Mologen AG. (3/27/19). "Press Release: Top Pharma Manager Stefan M. Manth, MD, to Become CEO of Mologen AG". Berlin. 2019-03-27
Genfit S.A.. (3/27/19). "Press Release: Genfit Announces Pricing of Global Offering and Approval to List on Nasdaq Global Select Market". Lille & Cambridge, MA. 2019-03-27
Curetis N.V.. (3/26/19). "Press Release: Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero". Amsterdam & Holzgerlingen. 2019-03-26
Cytena GmbH. (3/26/19). "Press Release: EUR 3 Million in Series A for the Growth and Development of Cytena GmbH". 2019-03-26
Evotec AG. (3/26/19). "Press Release: Evotec and The Mark Foundation for Cancer Research Announce Strategic Collaboration in Immuno-oncology". Hamburg. 2019-03-26
Synerkine Pharma B.V.. (3/25/19). "Press Release: Synerkine Pharma Raises EUR3.3 Million in Series A Financing". Utrecht. 2019-03-25
Pierre Fabre S.A.. (3/21/19). "Press Release: Institut Curie and Pierre Fabre Strengthen Their Immuno-oncology Partnership". Paris & Castres. 2019-03-21
4SC AG. (3/20/19). "Press Release: 4SC AG Provides Results for Financial Year 2018 and Outlook". Planegg-Martinsried. 2019-03-20
Vivet Therapeutics S.A.S.. (3/20/19). "Press Release: Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics". Paris & New York, NY. 2019-03-20
Oncimmune Holdings plc. (3/19/19). "Press Release: Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling". Cambridge, MA. 2019-03-19
Roche. (3/19/19). "Press Release: FDA Approves Roche’s Tecentriq in Combination with Chemotherapy for the Initial Treatment of Adults with Extensive-stage Small Cell Lung Cancer". Basel. 2019-03-19
Affimed N.V.. (3/19/19). "Press Release: Affimed Announces Milestone Payment from Genentech and ROCK Platform Presentation at Innate Killer Summit 2019, Further Highlighting Leadership in Innate Immunity". Heidelberg. 2019-03-19
Mologen AG. (3/18/19). "Press Release: Early Departure of CEO". Berlin. 2019-03-18
Celyad S.A.. (3/18/19). "Press Release: Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates". Mont-Saint-Guibert. 2019-03-18
SilverSky LifeSciences GmbH. (3/18/19). "Press Release: DxPx – The First International Diagnostics Partnering Conference". Düsseldorf. 2019-03-18
CARB-X. (3/14/19). "Press Release: Germany Joins CARB-X Partnership in the Fight against Deadly Drug-resistant Superbugs". Berlin. 2019-03-14
Abivax S.A.. (3/14/19). "Press Release: Abivax 2018 Financial Results and Operations Update". Paris. 2019-03-14
Merck KGaA. (3/14/19). "Press Release: Merck Announces Collaboration with Iktos for Generative Artificial Intelligence (AI) Technology [Not intended for US, Canada and UK-based media]". Darmstadt. 2019-03-14
Oxford BioMedica plc. (3/14/19). "Press Release: Oxford Biomedica plc Preliminary Results for the Year Ended 31 December 2018". Oxford. 2019-03-14
Bruker Corporation. (3/14/19). "Press Release: Bruker Announces Acquisition of Scientific Software Provider Arxspan". Billerica, MA. 2019-03-14
Genfit S.A.. (3/14/19). "Press Release: Genfit Announces Launch of Proposed Global Offering and Nasdaq Listing". Lille & Cambridge, MA. 2019-03-14
Argenx SE. (3/14/19). "Press Release: Argenx to Receive First Clinical Milestone Payment for Product Candidate Developed". Breda & Ghent. 2019-03-14
MorphoSys AG. (3/13/19). "Press Release: MorphoSys Presents Results for Fiscal Year 2018". Planegg. 2019-03-13
iOnctura S.A.. (3/12/19). "Press Release: iOnctura Bolsters Management Team with Senior Appointments. Michael Lahn Appointed Chief Medical Officer – Zoë Johnson Appointed Chief Scientific Officer". Geneva. 2019-03-12
Minoryx Therapeutics S.L.. (3/12/19). "Press Release: Minoryx Therapeutics Appoints Didier Le Normand as Group Chief Financial Officer (CFO) and General Manager of Its Belgian Subsidiary". Mataró, Barcelona & Charleroi. 2019-03-12
Abivax S.A.. (3/11/19). "Press Release: Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn’s and Colitis Organisation (ECCO)". Paris. 2019-03-11
Tecan Group Ltd.. (3/11/19). "Press Release: Tecan Reports Strong Second Half and a Very Successful Fiscal Year 2018". Männedorf. 2019-03-11
Snipr Biome ApS. (3/11/19). "Press Release: Snipr Biome Raises $50 Million Series A Financing to Advance CRISPR-based Microbiome Drugs to Human Clinical Trials". Copenhagen. 2019-03-11
Tecan Group Ltd.. (3/8/19). "Press Release: Qiagen and Tecan Announce Collaboration to Streamline Preanalytical Processing of QuantiFERON-TB Gold Plus". Männedorf, Germantown, MD & Hilden. 2019-03-08
Celyad S.A.. (3/8/19). "Press Release: Celyad Appoints Anne Moore as Vice President Corporate Strategy". Mont-Saint-Guibert. 2019-03-08
H. Lundbeck A/S. (3/8/19). "Press Release: Lundbeck Appoints Keld Flintholm Jørgensen as EVP and Chief Business Officer". Valby. 2019-03-08
Gilde Healthcare Partners. (3/7/19). "Press Release: Gilde Healthcare Raises €200 Million for New Private Equity Fund. Targeting Lower Mid-market Healthcare Investments in the Benelux and DACH Regions". Utrecht & Frankfurt a. M.. 2019-03-07
Boehringer Ingelheim. (3/7/19). "Press Release: Novel Antibody Shows Potential to Transform Treatment of Rare Form of Psoriasis". Ingelheim. 2019-03-07
MorphoSys AG. (3/7/19). "Press Release: MorphoSys Provides Updates on L-MIND and B-MIND Clinical Trials of MOR208 in Relapsed/Refractory DLBCL". Planegg. 2019-03-07
Seres Therapeutics, Inc.. (3/6/19). "Press Release: Seres Therapeutics Reports Fourth Quarter and Full Year Financial Results and Provides Operational Updates". Cambridge, MA. 2019-03-06
Sartorius AG. (3/5/19). "Press Release: Sartorius Stedim Biotech and Novasep to Develop Novel Systems for Membrane Chromatography". Göttingen. 2019-03-05
Kiadis Pharma N.V.. (3/5/19). "Press Release: Kiadis Pharma Strengthens Management Team". Amsterdam. 2019-03-05
Merck KGaA. (3/5/19). "Press Release: Open Letter to Versum Shareholders from Merck". Darmstadt. 2019-03-05
Eurofins Scientific. (3/5/19). "Press Release: Eurofins Delivers Solid FY 2018 Results with Revenues of EUR 3,781m (+27% yoy) and Adjusted EBITDA of EUR 720m (19.0% of revenues), in Line with Its Recently Upgraded Objectives". 2019-03-05
Seventure Partners. (3/5/19). "Press Release: Health for Life Capital II, World Leading Microbiome-focused Fund Announces its First Close". Paris. 2019-03-05
Nightstar Therapeutics plc. (3/4/19). "Press Release: Nightstar Therapeutics plc Reaches Agreement to Be Acquired by Biogen". 2019-03-04
NovoGo Therapeutics AG. (3/4/19). "Press Release: NovaGo Therapeutics Raises CHF 10 Million to Develop Regenerative Anti-Nogo Therapy for Stroke". Zurich. 2019-03-04
Merck KGaA. (3/4/19). "Press Release: Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology". Darmstadt. 2019-03-04
Enzymicals AG. (3/4/19). "Press Release: abcr GmbH and Enzymicals AG Deepen the Cooperation". Greifswald & Karlsruhe. 2019-03-04
UCB S.A.. (3/1/19). "Press Release: New Data Affirms Strength of UCB Immuno-Dermatology Portfolio". Brussels. 2019-03-01
1 2 3 ... 113 114 115  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top